Phibro Animal Health Reports 10% Sales Growth in Q3 and Updates Financial Guidance

Key Facts

1The company achieved net sales of $383.5 million in the third quarter, a 10% increase compared to the previous year.

2Net income rose to $24.0 million, representing a 15% increase compared to the same quarter in 2025.

Phibro Animal Health Corporation (PAHC) reported robust financial results for the third quarter ended March 31, 2026, achieving net sales of $383.5 million. This performance represents a 10% increase compared to the previous year, highlighting the company's operational strength. Net income also saw a significant rise to $24.0 million, marking a 15% growth over the same quarter in 2025. Alongside these results, the company provided updated financial guidance for the full fiscal year ending June 30, 2026. This report serves to inform investors of Phibro's sustained growth trajectory within the animal health sector. The positive double-digit growth in both sales and income underscores the company's ability to enhance profitability amid current market conditions.